Jefferies Expects Continued Shire Growth - Houston Chronicle
|
Jefferies Expects Continued Shire Growth
Houston Chronicle, United States - 19 hours ago The company makes the ADHD drugs Vyvanse and Adderall XR, the latter of which will lose patent protection next year. Revenue from the epilepsy drug … |
Find Out More:
- HISD not meeting dyslexic students' needs, parents say - Houston Chronicle
- Parents: HISD not meeting dyslexic students' needs - Houston Chronicle
- Schools fail to meet law on dyslexia - Houston Chronicle
- Bollywood takes aim at the pain of dyslexia - Houston Chronicle
- Literacy advocate to turn next page - Houston Chronicle
Books:
March 27th, 2008
Vyvanse
Leave a Reply